SCHEMBL29976146

SCHEMBL29976146

C=Cc1nc(N2CC3(CC3)C2)ccc1Cn1cnc(C(=O)OCC)c1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KLKB1 P03952 9/20 0.43
NOTUM Q6P988 1/20 0.36
KDM4E B2RXH2 3/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
RXFP1 Q9HBX9 1/20 0.35
KMT2A Q03164 1/20 0.35
AKT1 P31749 1/20 0.32
AKT2 P31751 1/20 0.32
CYP1A2 P05177 1/20 0.32
GABRA2 P47869 2/20 0.31
GABRB2 P47870 2/20 0.31
GAA P10253 1/20 0.31
POLB P06746 1/20 0.30
ALDH1A1 P00352 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23773002 1.00 KLKB1 (0.43) KLKB1NOTUMKDM4ENPC1RAB9A
SCHEMBL23769261 0.92 KLKB1 (0.44) KLKB1NOTUMKDM4ENPC1RAB9A
SCHEMBL21736739 0.88 KLKB1 (0.46) KLKB1NOTUMKDM4ENPC1RAB9A
SCHEMBL23754165 0.87 KLKB1 (0.47) KLKB1NOTUMKDM4ENPC1RAB9A
SCHEMBL29906650 0.87 KLKB1 (0.47) KLKB1NOTUMKDM4ENPC1RAB9A
SCHEMBL23753986 0.86 KLKB1 (0.45) KLKB1NOTUMKDM4ENPC1RAB9A
SCHEMBL23769158 0.86 KLKB1 (0.45) KLKB1NOTUMKDM4ENPC1RAB9A
SCHEMBL31357725 0.86 KLKB1 (0.45) KLKB1NOTUMKDM4ENPC1RAB9A
SCHEMBL23768889 0.86 KLKB1 (0.45) KLKB1NOTUMKDM4ENPC1RAB9A
SCHEMBL23769179 0.86 KLKB1 (0.48) KLKB1NOTUMKDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115087652-B Heteroaromatic carboxamide derivatives as inhibitors of plasma kallikrein 勃林格殷格翰国际有限公司 2024-05-07 CN disclosed
CN-115087652-A Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors 勃林格殷格翰国际有限公司 2022-09-20 CN disclosed